Adrenal Cancer Diagnostics Vehicle Market Trends, Outlook, Insights, Overview 2024-2033

The Adrenal Cancer Diagnostics Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

 Learn More On The Adrenal Cancer Diagnostics Market:
https://www.thebusinessresearchcompany.com/report/adrenal-cancer-diagnostics-global-market-report

According to The Business Research Company’s Adrenal Cancer Diagnostics Global Market Report 2024, The adrenal cancer diagnostics market size has grown strongly in recent years. It will grow from $130.84 billion in 2023 to $140.35 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%.  The  growth in the historic period can be attributed to increased incidence and awareness, genetic and molecular testing advances, biopsy techniques improvement, enhanced endocrine testing, integration of artificial intelligence (ai).

The adrenal cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $180.09 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%.  The growth in the forecast period can be attributed to personalized medicine approaches, rise in minimally invasive procedures, telemedicine and remote consultations, liquid biopsy development, expanded genetic counseling services. Major trends in the forecast period include regulatory support for diagnostic innovations, digital pathology adoption, advancements in imaging technologies, liquid biopsy development, genomic profiling for precision medicine.

The rising cigarette smoking is expected to propel the growth of the adrenal cancer diagnostics market going forward. Cigarette smoking refers to the act of inhaling and exhaling the fumes of burning tobacco, which contains nicotine, an addictive alkaloid that can have both stimulating and tranquilizing psychoactive effects. Cigarette smoking has been associated with an increased risk of adrenal cancer, including adrenal adenomas and adrenocortical carcinomas. The carcinogens in tobacco smoke can damage the DNA in adrenal cells, leading to mutations that can cause cancer. For instance, in July 2022, according to Statistics Canada, a Canada-based government agency, cigarette production increased by 5.8% compared to June 2021. Additionally, the total number of cigarettes sold rose 1.3% from May 2022, reaching 1.4 billion in June 2022. Therefore, the rising cigarette smoking is driving the growth of the adrenal cancer diagnostics market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13242&type=smp

The adrenal cancer diagnostics market covered in this report is segmented –

1) By Test: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, X-ray, Positron Emission Tomography (PET) Scan, Biopsy

2) By Treatment: Surgery, Chemotherapy, Radiotherapy, Targeted Cancer Therapies, Other Treatments

3) By Tumor Type: Pheochromocytoma, Adrenal Cortical Carcinoma, Other Types

4) By End-User: Hospitals, Ambulatory Surgical Centers, Cancer Centers, Other End-Users

Top Major Players:
Johnson And Johnson Pvt Ltd.
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific
GSK PLC
AstraZeneca PLC

North America was the largest region in the adrenal cancer diagnostics market in 2023.

Major companies operating in the adrenal cancer diagnostics market are developing innovative products with advanced technologies such as the High-V MRI platform and DryCool technology to increase their profitability in the market. The high-V MRI platform combines the power of digitalization with a new field strength of 0.55T, resulting in excellent diagnostic quality for routine and new clinical applications, whereas DryCool technology is a virtually helium-free scanner that uses a closed-loop cooling system to cool the magnet. For instance, in November 2021, Siemens Healthcare GmbH, a Germany-based healthcare company, introduced a new MRI scanner called Magnetom Free.Star1 for adrenal cancer diagnostics. The scanner is designed to be cost-effective and easy to operate, and it is based on Siemens Healthineers’ revolutionary High-V MRI platform and DryCool technology. It is expected to improve patient outcomes by enabling earlier and more accurate diagnosis of a wide range of medical conditions.

The adrenal cancer diagnostics market report table of contents includes:

1. Executive Summary
2. Adrenal Cancer Diagnostics Market Characteristics
3. Adrenal Cancer Diagnostics Market Trends And Strategies
4. Adrenal Cancer Diagnostics Market – Macro Economic Scenario
5. Global Adrenal Cancer Diagnostics Market Size and Growth
….
32. Global Adrenal Cancer Diagnostics Market Competitive Benchmarking
33. Global Adrenal Cancer Diagnostics Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Adrenal Cancer Diagnostics Market
35.Adrenal Cancer Diagnostics Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model